Cardiac biomarkers to characterize and predict heart dysfunction in relation to disease or metabolic states.
Targeting sector: Pharmaceutical and diagnostics companies.
Experimental tools to predict cardio-toxicity of drug compounds.
Targeting sector: Pharmaceutical companies
Discovery of novel cardiac therapies against pathophysiological states and metabolic diseases.
Targeting sector: Pharmaceutical and diagnostics companies.